PALIFERMIN SIGNIFICANTLY REDUCES SEVERE ORAL MUCOSITIS IN SUBJECTS WITH RESECTED LOCALLY ADVANCED HEAD AND NECK CANCER UNDERGOING POST-OPERATIVE CONCURRENT RADIO-CHEMOTHERAPY

被引:0
|
作者
Henke, M. [1 ]
Alfonsi, M. [2 ]
Foa, P. [3 ]
Giralt, J. [4 ]
Bardet, E. [5 ]
Cerezo, L. [6 ]
Salzwimmer, M. [7 ]
Whiley, M. [8 ]
Emmerson, L. [8 ]
Berger, D. [9 ]
机构
[1] Univ Klinikum Freiburg, Dept Radiooncol, Freiburg, Germany
[2] Inst St Catherine, Serv Radiotherapie, Avignon, France
[3] San Paolo Univ Hosp, Dept Oncol, Milan, Italy
[4] Vall dHebron Univ Hosp, Dept Radiat Oncol, Barcelona, Spain
[5] CRLCC Nantes Atlantiques, Nantes, France
[6] Hosp Univ Princesa, Radiat Oncol, Madrid, Spain
[7] Ear Nose & Throat Univ Hosp Graz, Dept Gen ENT, Graz, Austria
[8] Amgen Ltd, Cambridge, England
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
460
引用
收藏
页码:S152 / S152
页数:1
相关论文
共 34 条
  • [31] ROMAN: Phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC).
    Anderson, Carryn M.
    Lee, Christopher M.
    Kelley, Joseph Randall
    Walker, Gary V.
    Dunlap, Neal E.
    Bar-Ad, Voichita C.
    Miller, Douglas A.
    King, Vernon J.
    Peddada, Abhinand V.
    Ciuba, Douglas F.
    Vincent, Francois
    Muzyka, Brian C.
    Gillespie-Twardy, Amanda Lynn
    Sonis, Stephen T.
    Holmlund, Jon
    Saunders, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Tumor Outcomes for ROMAN: Phase 3 Trial of Avasopasem Manganese (GC4419) for Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiotherapy (CRT) for Locally Advanced Head and Neck Cancer (LAHNC)
    Anderson, C. M.
    Lee, C. M.
    Kelley, J. R.
    Walker, G. V.
    Dunlap, N.
    Bar-Ad, V.
    Miller, D. A.
    King, V. J., Sr.
    Peddada, A.
    Ciuba, D. F.
    Vincent, F.
    Muzyka, B. C.
    Gillespie-Twardy, A. L.
    Sonis, S.
    Holmlund, J.
    Saunders, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S97 - S98
  • [33] Indications and complications of prophylactic gastrostomy feeding tubes (PGTs) in the management of patients with advanced head & neck cancer (HNC) undergoing chemoradiation therapy (CRT) or combined modality surgery with post-operative radiotherapy (SRT)
    O'Connell, M.
    Freeman, L.
    Donnelly, R.
    Wong, T.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S84 - S84
  • [34] Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients:: An evaluation of effectiveness, safety and costs
    Mantovani, G
    Massa, E
    Astara, G
    Murgia, V
    Gramignano, G
    Lusso, MR
    Camboni, P
    Ferreli, L
    Mocci, M
    Perboni, S
    Mura, L
    Madeddu, C
    Macciò, A
    ONCOLOGY REPORTS, 2003, 10 (01) : 197 - 206